hypoxanthine has been researched along with Granulocytic Leukemia, Chronic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Meshkini, A; Yazdanparast, R | 1 |
Hata, Y; Natsumeda, Y; Weber, G | 1 |
Eble, JN; Hoffman, R; Jayaram, HN; Nagai, M; Natsumeda, Y; Paulik, E; Tricot, G; Weber, G; Zhen, WN | 1 |
1 trial(s) available for hypoxanthine and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient.
Topics: Adenine Nucleotides; Antimetabolites, Antineoplastic; Blast Crisis; Blotting, Northern; Down-Regulation; Gene Expression Regulation; Genes, ras; Guanosine Triphosphate; Humans; Hypoxanthine; Hypoxanthines; IMP Dehydrogenase; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pilot Projects; Ribavirin; RNA; Uric Acid | 1991 |
2 other study(ies) available for hypoxanthine and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Induction of megakaryocytic differentiation in chronic myelogenous leukemia cell K562 by 3-hydrogenkwadaphnin.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Differentiation; Diterpenes; Drug Resistance, Neoplasm; Enzyme Inhibitors; Guanosine; Humans; Hypoxanthine; IMP Dehydrogenase; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Megakaryocytes; Platelet Glycoprotein GPIIb-IIIa Complex; Polyploidy; Thrombopoiesis | 2007 |
Tiazofurin decreases Ras-GTP complex in K562 cells.
Topics: Antimetabolites, Antineoplastic; Cell Differentiation; Guanosine; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Hypoxanthine; Hypoxanthines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oncogene Protein p21(ras); Protein Binding; Ribavirin; Tumor Cells, Cultured | 1993 |